Dosage FDA Webinar 
European Pharmaceutical Review
APRIL 4, 2025
One of the most significant challenges is keeping up with the changing regulatory requirements set by agencies such as the US FDA, EMA and International Council for Harmonisation (ICH). For solid dosage forms, including capsules, tablets, or film-coated tablets, dissolution tests are conducted. Any identified gaps have been addressed.
Pharma Marketing Network
JUNE 3, 2025
Today, digital-first strategies dominate, emphasizing email marketing, display ads, social media, webinars, and branded content. All CTAs should align with FDA regulations and be vetted by MLR (Medical, Legal, Regulatory) teams. How can CTAs remain compliant with FDA guidelines? Learn more.” What makes a good CTA for HCPs?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
MARCH 3, 2025
Whether thats requesting medical samples, signing up for a webinar, or downloading patient education materials , CRO helps ensure visitors dont just browsethey take action. Offer interactive tools like symptom checkers and dosage calculators. But patients often abandon pages if content is confusing or lacks trust signals.
Pharmaceutical Technology
FEBRUARY 23, 2023
Biopharmaceutics is a scientific discipline that examines the interrelationship of the physicochemical properties of the drug, the dosage form in which the drug is given, and the route of administration on the rate and extent of systemic drug absorption ( Applied Biopharmaceutics and Pharmacokinetics, Shargel, Wu-Pong and Yu, 5th Edition ).
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
A recent draft from the FDA provides valuable insight. In this exclusive webinar, Dr. Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs. What will the future hold for clinical research?
PharmaVoice
JUNE 27, 2025
Despite worried hand-wringing over a potential slowdown in FDA approvals under the new administration, the agency has been giving the go-ahead to drugs at a near record-setting clip. Meanwhile, the decision-making production has come during a major upheaval inside the FDA. Please let us know if you have feedback.
Pharmacy Times
JUNE 17, 2025
A group of experts will present an encore abstract titled " Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using Real-World Data " at the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20.
Expert insights. Personalized for you.
64 
Let's personalize your content